Abstracts

Broadly Neutralizing Antibody-Secreting T Cells and CAR-Ts Potently Suppress In Vivo HIV Infection

Background: We hypothesized that combining anti-HIV CAR-T cells and with T cells engineered to secrete broadly neutralizing antibodies (bNAbs) could provide an approach to achieve ART-free HIV remission. As a proof-of-concept, we engineered a lentiviral vector (LV) encoding 3BNC117 bNAb (3BNC) to transduce T cells. We further evaluated the in vivo synergistic effects of 3BNC-expressed…

Selection of Epigenetically Privileged HIV-1 Proviruses During Treatment With Panobinostat and IFNα

Background: CD4 T cells with latent HIV-1 infection persist despite treatment with currently available antiretroviral agents and represent the main barrier to HIV-1 cure. Pharmacological disruption of viral latency may increase the immunological vulnerability of HIV-1 infected cells, but the efficacy of latency-reversing agents for reducing HIV-1 persistence remains to be proven Methods: We conducted…

A 4-Month Regimen of Quabodepistat, Delamanid, and Bedaquiline for Pulmonary TB: Interim Results

Background: There remains an urgent need for short-duration, potent, and safe anti-tuberculosis (TB) agents effective against drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis. Quabodepistat (QBS; formerly OPC-167832) is a novel anti-TB agent that targets decaprenylphosphoryl-β-D-ribose 2′-oxidase (DprE1). In a prior study, QBS in combination with delamanid (DLM) and bedaquiline (BDQ) for 14 days was well…

Provisional Results From a 3-month Clofazimine/Rifapentine-Containing Regimen for Drug-Sensitive TB

Background: Clo-Fast (ACTG A5362; NCT04311502) is a randomized, controlled, open-label phase IIc clinical trial evaluating the safety and efficacy of a 3-month rifapentine (P1200mg)/clofazimine (CFZ)-containing regimen versus 6-month standard of care (SOC) for drug-susceptible (DS) TB that stopped enrollment early due to lack of clinical efficacy. We present results from data through Sept 25, 2023,…

InSTI Switch During Menopause Is Associated With Accelerated Body Composition Change

Background: Integrase strand transfer inhibitors (INSTIs) have been associated with greater weight gain in women with HIV (WWH) than men with HIV. The transition to menopause is also associated with body composition changes. Whether INSTI initiation during the menopausal transition affects waist circumference (WC) and BMI trajectories is unknown. Methods: From 2006-2019, 1159 non-pregnant virally-suppressed…

IFNα2 Autoantibodies Post-SARS-CoV-2 Wave 1 in India Are Associated With Lower Omicron Symptomology

Background: Neutralizing autoantibodies against type I IFNs have been associated with life-threatening SARS-CoV-2 infection in the first wave of the pandemic. As part of a wider immunophenotyping study aimed at comparing susceptibility and immunopathogenesis of COVID-19 between the UK and India, we examined the levels of anti-IFNα2 neutralization in sera collected. Methods: We used sera…